Home
Scholarly Works
Two-Year Efficacy and Safety of Benralizumab for...
Journal article

Two-Year Efficacy and Safety of Benralizumab for the Treatment of Eosinophilic Granulomatosis with Polyangiitis

Authors

Wechsler M; Nair P; Khalidi N; Terrier B; Hellmich B; Bourdin A; Jayne D; Jackson D; Roufosse F; Pagnoux C

Journal

The Journal of Allergy and Clinical Immunology, Vol. 155, No. 2,

Publisher

Elsevier

Publication Date

February 1, 2025

DOI

10.1016/j.jaci.2024.12.981

ISSN

0091-6749

Contact the Experts team